Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase-2: a therapeutic target.

Marco E Turini1, Raymond N DuBois

  • 1Department of Nutrition, Nestlé Research Center, CH-1000 Lausanne 26, Switzerland.

Annual Review of Medicine
|January 31, 2002
PubMed
Summary

Cyclooxygenase (COX) enzymes, COX-1 and COX-2, play critical roles in both normal bodily functions and disease processes. Understanding their distinct roles informs the development of targeted anti-inflammatory drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peroxisome Proliferator-Activated Receptor δ Suppresses the Cytotoxicity of CD8+ T Cells by Inhibiting RelA DNA-Binding Activity.

Cancer research communications·2024
Same author

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.

Cancer research communications·2023
Same author

Micronutrient intakes in the Dutch diet: foods, fortified foods and supplements in a cross sectional study.

European journal of nutrition·2023
Same author

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

Molecular cancer research : MCR·2022
Same author

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

Molecular cancer therapeutics·2022
Same author

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

Cancer research·2022

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Cyclooxygenase (COX) enzymes catalyze the conversion of arachidonic acid to prostaglandins.
  • Two isoforms, COX-1 and COX-2, have been identified with distinct expression patterns.
  • COX-1 is constitutively expressed, maintaining normal physiological functions.
  • COX-2 is inducible, particularly at sites of inflammation and in cancer.

Purpose of the Study:

  • To review the current understanding of COX-1 and COX-2 roles.
  • To differentiate the physiological and pathological functions of COX isoforms.
  • To discuss the implications for drug development, including NSAIDs and COXIBs.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of studies on COX enzyme function and regulation.
  • Synthesis of information regarding COX-1 and COX-2 in health and disease.

Main Results:

  • COX-1 is essential for gastrointestinal mucosal integrity and platelet function.
  • COX-2 is upregulated during inflammation, pain, and tumorigenesis.
  • Traditional NSAIDs inhibit both COX isoforms, leading to potential side effects.
  • COX-2 selective inhibitors (COXIBs) offer targeted inhibition with potentially fewer gastrointestinal adverse effects.

Conclusions:

  • COX-1 and COX-2 exhibit distinct physiological and pathological roles.
  • Targeting COX-2 offers therapeutic potential for inflammatory conditions and cancer.
  • Further research is needed to fully elucidate the complex roles of COX enzymes.

Related Experiment Videos